• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血糖正常和糖尿病前期受试者之间血糖变异性的差异。

Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects.

作者信息

Hanefeld Markolf, Sulk Stefan, Helbig Matthias, Thomas Andreas, Köhler Carsta

机构信息

Study Centre Prof. Hanefeld, GWT-TUD GmbH, Dresden, Germany

Study Centre Prof. Hanefeld, GWT-TUD GmbH, Dresden, Germany.

出版信息

J Diabetes Sci Technol. 2014 Mar;8(2):286-290. doi: 10.1177/1932296814522739. Epub 2014 Mar 2.

DOI:10.1177/1932296814522739
PMID:24876580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4455406/
Abstract

So far the criteria for NGT and abnormal glucose tolerance (AGT) are based on HbA1c and 75 g oGTT. We present data on GV and diurnal profiles in stratified cohorts with AGT versus controls. 28 NGT, 42 AGT (15 IGT, 11 IFG, 16 CGI) matched for age and BMI classified by 75 g oGTT underwent a CGM with test meal (TM). Diurnal profiles, glucose excursion after TM, and GV (SD, MAGE) were calculated for day 2 and 3. HbA1c, with its values of 5.5 ± 0.37% versus 5.65 ± 0.36%, was within normal range. Average interstitial glucose (AiG) was 5.84 ± 0.52 mmol/l) in NGT and 6.35 ± 0.65 mmol/l in AGT (P = .002). The 2 h incremental area under curve (iAUC) from TM until 2 h after TM was 1.94 ± 1.31 mmol/lh versus 2.89 ( ± 1.75) mmol/lh (P = .012), AiG 2 hours after TM was 5.99 ± 1.14 mmol/ld versus 6.64 ± 1.30 mmol/l (P = .035). Peaks of AiG after TM were 7.69 ± 1.48 mmol/ld versus 9.18 ± 1.67 mmol/l*d (P = .001). SD was significantly higher for AGT (1.12 ± 0.37 vs. 0.85 ± 0.32 mmol/l, P = .01) and MAGE 2.26 ± 0.84 vs. 1.60 ± 0.69 mmol/l, P = .005). In this comparative analysis NGT and AGT well matched for age, BMI, and comorbidities, CGM revealed significant differences in daytime AiG, pp glucose excursion and postprandial peaks. SD and MAGE was significantly higher for subjects with AGT. I Impaired glucose homeostasis a better characterizes degree of AGTe than HbA1c and 75 g OGTT.

摘要

到目前为止,正常糖耐量(NGT)和异常糖耐量(AGT)的标准是基于糖化血红蛋白(HbA1c)和75克口服葡萄糖耐量试验(oGTT)。我们展示了AGT分层队列与对照组的血糖变异性(GV)和昼夜血糖谱数据。28例NGT患者、42例AGT患者(15例糖耐量受损[IGT]、11例空腹血糖受损[IFG]、16例化学性血糖不稳定[CGI]),根据75克oGTT按年龄和体重指数(BMI)匹配,接受了含试验餐(TM)的连续血糖监测(CGM)。计算了第2天和第3天的昼夜血糖谱、试验餐后的血糖波动以及GV(标准差[SD]、平均血糖波动幅度[MAGE])。HbA1c值分别为5.5±0.37%和5.65±0.36%,均在正常范围内。NGT组的平均组织间液葡萄糖(AiG)为5.84±0.52毫摩尔/升,AGT组为6.35±0.65毫摩尔/升(P = 0.002)。从试验餐到试验餐后2小时的2小时曲线下增量面积(iAUC)分别为1.94±1.31毫摩尔/升·小时和2.89(±1.75)毫摩尔/升·小时(P = 0.012),试验餐后2小时的AiG分别为5.99±1.14毫摩尔/升·天和6.64±1.30毫摩尔/升(P = 0.035)。试验餐后AiG的峰值分别为7.69±1.48毫摩尔/升·天和9.18±1.67毫摩尔/升·天(P = 0.001)。AGT组的SD显著更高(1.12±0.37对0.85±0.32毫摩尔/升,P = 0.01),MAGE分别为2.26±0.84和1.60±0.69毫摩尔/升,P = 0.005)。在这项对比分析中,NGT组和AGT组在年龄、BMI和合并症方面匹配良好,CGM显示白天AiG、餐后血糖波动和餐后峰值存在显著差异。AGT受试者的SD和MAGE显著更高。与HbA1c和75克口服葡萄糖耐量试验相比,葡萄糖稳态受损能更好地表征AGT的程度。

相似文献

1
Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects.血糖正常和糖尿病前期受试者之间血糖变异性的差异。
J Diabetes Sci Technol. 2014 Mar;8(2):286-290. doi: 10.1177/1932296814522739. Epub 2014 Mar 2.
2
[Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].[不同亚型糖耐量受损患者血糖波动特征]
Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):669-72.
3
Difference on Glucose Profile From Continuous Glucose Monitoring in People With Prediabetes vs. Normoglycemic Individuals: A Matched-Pair Analysis.**标题**:在糖尿病前期患者与血糖正常个体中,基于连续血糖监测的葡萄糖谱差异:一项配对分析。
J Diabetes Sci Technol. 2024 Mar;18(2):414-422. doi: 10.1177/19322968221123530. Epub 2022 Sep 13.
4
Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.肥胖的 2 型糖尿病患者一级亲属的 CGMS 异常血糖谱。
Diabetes Technol Ther. 2013 Jun;15(6):461-5. doi: 10.1089/dia.2012.0333. Epub 2013 Apr 30.
5
Impaired fasting glucose is not a risk factor for atherosclerosis.空腹血糖受损并非动脉粥样硬化的危险因素。
Diabet Med. 1999 Mar;16(3):212-8. doi: 10.1046/j.1464-5491.1999.00072.x.
6
Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.口服葡萄糖耐量试验和持续葡萄糖监测以评估囊性纤维化患者糖尿病的发生情况。
Endocrinol Diabetes Nutr (Engl Ed). 2018 Jan;65(1):45-51. doi: 10.1016/j.endinu.2017.08.008. Epub 2017 Nov 12.
7
Glycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus.既往有妊娠期糖尿病的糖耐量正常女性的血糖变异性
Diabetol Metab Syndr. 2015 Sep 24;7:82. doi: 10.1186/s13098-015-0077-5. eCollection 2015.
8
Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance.血糖变异性与不同糖耐量阶段受试者口服处置指数的关系。
Diabetol Metab Syndr. 2013 Jul 23;5:38. doi: 10.1186/1758-5996-5-38. eCollection 2013.
9
[Characteristics of real-life glucose profiles monitored by continuous glucose monitoring system in persons with normal glucose tolerance].[连续血糖监测系统监测的糖耐量正常者实际生活中的血糖谱特征]
Zhonghua Yi Xue Za Zhi. 2012 Jul 10;92(26):1820-3.
10
[Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].1193例原发性高血压住院患者的胰岛素分泌与胰岛素敏感性
Zhonghua Nei Ke Za Zhi. 2004 Oct;43(10):735-9.

引用本文的文献

1
Improved detection of decreased glucose handling capacities via continuous glucose monitoring-derived indices.通过连续葡萄糖监测得出的指标,改善对葡萄糖处理能力下降的检测。
Commun Med (Lond). 2025 Apr 22;5(1):103. doi: 10.1038/s43856-025-00819-5.
2
Impact of Glucose Profile, Fasting Insulin, and Renal Function on Sarcopenia in Elderly at Single Centered Nursing Home: A Cross-Sectional Structural Equation Model Analysis.单中心养老院老年人血糖谱、空腹胰岛素及肾功能对肌肉减少症的影响:横断面结构方程模型分析
J Multidiscip Healthc. 2025 Mar 6;18:1393-1404. doi: 10.2147/JMDH.S486370. eCollection 2025.
3
The sleep for health study: A randomized clinical trial of the impact of insomnia treatment on glycemia in people with prediabetes.睡眠对健康的影响研究:一项关于失眠治疗对糖尿病前期患者血糖影响的随机临床试验。
Contemp Clin Trials. 2025 Feb;149:107796. doi: 10.1016/j.cct.2024.107796. Epub 2024 Dec 25.
4
Continuous Glucose Monitoring for the Diagnosis of Post-Transplantation Diabetes Mellitus and Impaired Glucose Tolerance From Years One to Five After Kidney Transplantation-A Prospective Pilot Study.肾移植后1至5年持续血糖监测用于诊断移植后糖尿病和糖耐量受损——一项前瞻性试点研究
Transpl Int. 2024 Nov 15;37:13724. doi: 10.3389/ti.2024.13724. eCollection 2024.
5
Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?连续血糖监测用于糖尿病前期:最佳指标是什么?
J Diabetes Sci Technol. 2024 Jul;18(4):835-846. doi: 10.1177/19322968241242487. Epub 2024 Apr 17.
6
The effect of sucrase-isomaltase deficiency on metabolism, food intake and preferences: protocol for a dietary intervention study.蔗糖酶-异麦芽糖酶缺乏对代谢、食物摄入和偏好的影响:饮食干预研究方案。
Int J Circumpolar Health. 2023 Dec;82(1):2178067. doi: 10.1080/22423982.2023.2178067. Epub 2023 Feb 22.
7
Analytical Performance of the Factory-Calibrated Flash Glucose Monitoring System FreeStyle Libre2 in Healthy Women.工厂校准的瞬态葡萄糖监测系统 FreeStyle Libre2 在健康女性中的分析性能。
Sensors (Basel). 2023 Aug 25;23(17):7417. doi: 10.3390/s23177417.
8
The Relationship Between Dietary Patterns and Glycemic Variability in People with Impaired Glucose Tolerance.膳食模式与糖耐量受损人群血糖变异性的关系。
J Nutr. 2023 May;153(5):1427-1438. doi: 10.1016/j.tjnut.2023.03.007. Epub 2023 Mar 10.
9
Difference on Glucose Profile From Continuous Glucose Monitoring in People With Prediabetes vs. Normoglycemic Individuals: A Matched-Pair Analysis.**标题**:在糖尿病前期患者与血糖正常个体中,基于连续血糖监测的葡萄糖谱差异:一项配对分析。
J Diabetes Sci Technol. 2024 Mar;18(2):414-422. doi: 10.1177/19322968221123530. Epub 2022 Sep 13.
10
Continuous glucose monitoring metrics for earlier identification of pre-diabetes: protocol for a systematic review and meta-analysis.连续血糖监测指标在早期识别糖尿病前期中的应用:系统评价和荟萃分析的方案。
BMJ Open. 2022 Aug 25;12(8):e061756. doi: 10.1136/bmjopen-2022-061756.

本文引用的文献

1
Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test.糖化血红蛋白在糖尿病及糖尿病前期诊断中的应用以及空腹血糖、口服葡萄糖耐量试验的作用
Int J Prev Med. 2013 Sep;4(9):1025-9.
2
A consensus perceived glycemic variability metric.一种共识性的可感知血糖变异性指标。
J Diabetes Sci Technol. 2013 Jul 1;7(4):871-9. doi: 10.1177/193229681300700409.
3
Standards of medical care in diabetes--2013.《糖尿病医疗护理标准——2013》
Diabetes Care. 2013 Jan;36 Suppl 1(Suppl 1):S11-66. doi: 10.2337/dc13-S011.
4
Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.不同种族无糖尿病受试者的连续血糖监测的平均组织葡萄糖和血糖变异性的正常参考范围。
Diabetes Technol Ther. 2011 Sep;13(9):921-8. doi: 10.1089/dia.2010.0247. Epub 2011 Jun 29.
5
Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus.2型糖尿病患者糖化血红蛋白达标、无症状低血糖风险与血糖变异性之间的关系。
Exp Clin Endocrinol Diabetes. 2011 Jan;119(1):59-61. doi: 10.1055/s-0030-1262874. Epub 2011 Jan 18.
6
Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring.应用连续血糖监测建立中国人群血糖波动的正常参考范围。
Med Sci Monit. 2011 Jan;17(1):CR9-13. doi: 10.12659/msm.881318.
7
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.基础胰岛素甘精胰岛素控制正常空腹血糖水平对血糖变异性和低血糖风险的影响:早期 2 型糖尿病患者的随机对照研究。
Diabet Med. 2010 Feb;27(2):175-80. doi: 10.1111/j.1464-5491.2009.02915.x.
8
The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles.“葡萄糖五边形”:通过整合来自血糖谱的不同参数的模型评估糖尿病患者的血糖控制情况。
Diabetes Technol Ther. 2009 Jun;11(6):399-409. doi: 10.1089/dia.2008.0119.
9
Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.使用连续血糖监测和动态血糖图谱分析来描述糖耐量正常个体的葡萄糖暴露情况。
Diabetes Technol Ther. 2008 Jun;10(3):149-59. doi: 10.1089/dia.2007.0293.
10
Glycemic variability: should we and can we prevent it?血糖变异性:我们应该且能够预防它吗?
Diabetes Care. 2008 Feb;31 Suppl 2:S150-4. doi: 10.2337/dc08-s241.